NORFOLK-The Children’s Hospital of The King’s Daughters (CHKD) recently announced the upcoming retirement of the health system’s president and CEO.
Jim Dahling will retire in 2023 after nearly 30 years with CHKD, the board of directors shared on Friday, December 2.
The health system’s board of directors has chosen Amy Sampson, senior vice president, chief engagement and innovation officer, to succeed Dahling. In addition, Dr. Christopher Foley, vice president, chief of medicine, will take on the role of chief clinical operations officer, a position that was recently created to replace the position of chief operating officer.
“The board extends immense gratitude to Jim for his visionary leadership,” said Akhil Jain, chair of the board of directors, in a statement. “His tenure marked an era of critical expansion for the health system, improving access to pediatric services and aligning CHKD with major shifts in the delivery of healthcare.”
Dahling first joined the CHKD team in 1994 and has been at the helm of the health system since 2003.
“It has been a privilege to lead this organization,” he said. “CHKD is a remarkable family of extraordinary clinicians, surrounded by exceptional team members and bolstered by our King’s Daughters and volunteers, all of whom are steadfast in their dedication to doing what is best and right for children. I am in awe of their compassion, their commitment to excellence, and their resilience, and I am confident they will continue to grow and flourish with Amy’s insightful and inspirational leadership, and Chris’ knowledge and experience of clinical operations.”
Sampson has been a part of CHKD since 1990, while Foley has been with the health system since 1996.